قصتنا
نحن تحديث مختبرات مع التحكم في بناء مباشر التسليم ، منظمة العفو الدولية قرار الدعم و المراجعة جاهزة الأدلة بالإضافة إلى التدريب الموجه عند الحاجة.
تركيزنا
عندما مختبرات منقوصا المرضى دفع الثمن—و النظم الصحية تخسر الملايين. عادة, تكنولوجيا, سير العمل, البيانات, و الامتثال ليست متكاملة. DealBridge ينسجم مع التحكم في التنفيذ ، منظمة العفو الدولية قرار دعم التميز التشغيلي وإدارة المخاطر والتدقيق-أدلة على استعداد لتقديم أكثر أمانا الرعاية للقياس ومراقبة التكاليف.
منظمة العفو الدولية قرار
DealBridge العالمية بنيت لسبب واحد: عالية المخاطر تشخيص المشاريع تفشل عندما خطط لا تتحول إلى التنفيذ والمساءلة فواصل بين الفرق و البائعين. نحن محاذاة الاحتياجات السريرية العمليات والموردين الحكم في واحدة تسيطر تسليم منظومة معقدة العمل ، ينفذ, و تقدم نتائج قابلة للقياس.
يقابلنا
مؤسس تقودها القيادة المعززة من قبل كبار المستشارين في مختبر الطب, علم الأمراض, الجودة, مختبر البيانات & AI. نأتي الحكم و تسليم الانضباط الذي يحمي المرضى ، والميزانيات ، والنتائج.
Founder & Managing Director | DealBridge Global
Dr. Ghulam Dhabaan, PhD, FCCM, D(ABMM), is a board-certified Clinical Microbiologist and Founder of DealBridge Global, a diagnostics advisory, innovation, and execution firm. Trained across University of Toronto–affiliated hospitals, he specializes in transforming complex laboratory systems into high-performance, outcome-driven operations. His work integrates AI-enabled diagnostics, automation, and antimicrobial stewardship to bridge the gap between data, decisions, and clinical impact. Published in Nature Microbiology and The Lancet Microbe, he advises on large-scale diagnostic transformation initiatives across North America and the GCC.
Professor & Head, Clinical Biochemistry | SickKids & University of Toronto | Past President, IFCC
Dr. Khosrow Adeli is Professor and Head of Clinical Biochemistry at the Hospital for Sick Children and the University of Toronto. He served as President of the IFCC (2020–2023) and is Editor-in-Chief of Critical Reviews in Clinical Laboratory Sciences. A fellow of the Canadian Academy of Clinical Biochemistry and diplomate of the American Board of Clinical Biochemistry, he has received numerous distinctions including the University of Toronto Hegele Award and the ADLM Outstanding Research Award. Principal Investigator of the globally adopted CALIPER pediatric reference interval database. Author of 500+ publications.
Professor & Microbiologist-in-Chief, Sinai Health & University Health Network | University of Toronto
Dr. Tony Mazzulli, MD, FRCPC, FACP, is a leading authority in clinical microbiology, infectious diseases, and diagnostic innovation. He serves as Microbiologist-in-Chief at Sinai Health and University Health Network and is a Professor and Clinician Investigator at the University of Toronto. A recognized leader in antimicrobial resistance, virology, and rapid diagnostics, he has authored over 150 peer-reviewed publications and led major laboratory responses to emerging pathogens. Dr. Mazzulli holds key advisory roles with CLSI and national specialty bodies, and has directed premier training programs, shaping the next generation of clinical microbiology leadership.
Founder & MD, Q3CG | Executive Director, QRI | Ann Arbor, Michigan
Dr. Walid Qoronfleh is Executive Director of Q3 Research Institute (QRI) and co-Founder of Q3CG, a boutique healthcare consultancy in Michigan. With 20+ years in precision medicine, AI, and laboratory medicine, he has held senior executive roles at GSK, Sanofi, Thermo Fisher, and the NIH-NCI. He has secured nearly US$20M in funded research and published 145+ peer-reviewed papers and four books, including a best-book award winner. Founder of six biotech companies with three successful exits. Holds graduate degrees from the University of Louisville, Penn State, and University of Wisconsin–Madison.
Chief operating Officer, Diagnostic Center, American Hospital Dubai
Dr. Hady is Chief Operating Officer of the Diagnostic Centre at American Hospital Dubai, where he provides strategic leadership across Medical Imaging and Laboratory Medicine. He brings extensive expertise in healthcare operations, laboratory medicine, diagnostic service optimization, system integration, quality governance, and performance management. His work focuses on workflow redesign, turnaround-time improvement, service expansion, accreditation readiness, and data-informed operational governance. As a strategic advisor, he combines clinical insight, operational execution, and financial stewardship to build high-performing diagnostic services that improve patient care and long-term organizational value.
Vice President-Royal College of Pathologists. Consultant Medical Microbiology, UK
Dr. Noha El Sakka OBE is a senior UK leader in laboratory medicine, medical microbiology, and virology. She serves as Consultant Medical Microbiologist, Clinical Director of Laboratory Medicine in NHS Aberdeen, and Vice President of the Royal College of Pathologists. She oversees laboratory services spanning more than 400 staff, major budgets, workforce, LIMS, finance, quality, and UKAS ISO 15189 accreditation. Her national leadership includes training standards, examinations, guideline development, CPD, and advisory roles with the Scottish Government and Chief Medical Officer.
Professor & Consultant Microbiologist at King Saud University & Medical City
Dr. Ali M. Somily is Professor at the College of Medicine, King Saud University, and Consultant Microbiologist at King Saud University Medical City. He holds FRCP(C), D(ABMM), FCCM, MPH, and CIC credentials, with expertise in medical microbiology, epidemiology, biostatistics, infectious diseases, and infection prevention. He also serves as Editor-in-Chief of the University’s Journal of Nature and Science of Medicine and advises key governmental health agencies, including Weqaya, the National Public Health Laboratory, and the Armed Forces Medical Services in Saudi Arabia.
Translating laboratory expertise, data, and AI into practical, governed solutions that improve diagnostics, workflow, and performance.
AI Technical Lead | DealBridge Global | Clinical AI & Data | Berlin, Germany|
Christopher Danz is an applied AI and data leader specializing in healthcare system transformation. With a physics background and several years as an ML Engineer, he leads the AI and data department at DRK Kliniken Berlin – one of Germany's largest multi-site hospital groups – building clinical AI infrastructure in a complex, regulated environment. His work spans on-premise AI deployment, clinical data architecture, and regulation-aligned governance. As a practitioner and speaker on healthcare AI transformation, he grounds DealBridge's AI delivery in operational reality.
يقابلنا
مؤسس تقودها القيادة المعززة من قبل كبار المستشارين في مختبر الطب, علم الأمراض, الجودة, مختبر البيانات & AI. نأتي الحكم و تسليم الانضباط الذي يحمي المرضى ، والميزانيات ، والنتائج.
Founder & Managing Director | DealBridge Global
Dr. Ghulam Dhabaan, PhD, FCCM, D(ABMM), is a board-certified Clinical Microbiologist and Founder of DealBridge Global, a diagnostics advisory, innovation, and execution firm. Trained across University of Toronto–affiliated hospitals, he specializes in transforming complex laboratory systems into high-performance, outcome-driven operations. His work integrates AI-enabled diagnostics, automation, and antimicrobial stewardship to bridge the gap between data, decisions, and clinical impact. Published in Nature Microbiology and The Lancet Microbe, he advises on large-scale diagnostic transformation initiatives across North America and the GCC.
Professor & Head, Clinical Biochemistry | SickKids & University of Toronto | Past President, IFCC
Dr. Khosrow Adeli is Professor and Head of Clinical Biochemistry at the Hospital for Sick Children and the University of Toronto. He served as President of the IFCC (2020–2023) and is Editor-in-Chief of Critical Reviews in Clinical Laboratory Sciences. A fellow of the Canadian Academy of Clinical Biochemistry and diplomate of the American Board of Clinical Biochemistry, he has received numerous distinctions including the University of Toronto Hegele Award and the ADLM Outstanding Research Award. Principal Investigator of the globally adopted CALIPER pediatric reference interval database. Author of 500+ publications.
Founder & MD, Q3CG | Executive Director, QRI | Ann Arbor, Michigan
Dr. Walid Qoronfleh is Executive Director of Q3 Research Institute (QRI) and co-Founder of Q3CG, a boutique healthcare consultancy in Michigan. With 20+ years in precision medicine, AI, and laboratory medicine, he has held senior executive roles at GSK, Sanofi, Thermo Fisher, and the NIH-NCI. He has secured nearly US$20M in funded research and published 145+ peer-reviewed papers and four books, including a best-book award winner. Founder of six biotech companies with three successful exits. Holds graduate degrees from the University of Louisville, Penn State, and University of Wisconsin–Madison.
Group Laboratory Director, Operations & Innovation | American Hospital Dubai
Dr. Hady Elkhodary is a healthcare executive and clinical laboratory leader with 20+ years optimizing diagnostics across Canada and the Middle East. As Group Laboratory Director at American Hospital Dubai, he steers multi-site total laboratory automation, genomics expansion, and data-driven quality programs that have reduced turnaround times and delivered millions in operational savings. A recognized expert in ISO 15189 and CAP accreditation, LIS integration (Oracle Health, TrakCare), and value-based care strategy, he consults with GCC health systems on operational excellence and advances predictive analytics to close diagnostic gaps.
الأساس المنطقي
DealBridge العالمية بنيت بعد رؤية نفس الفشل نمط في تشخيص برامج: المرضى للخطر ، والنظم الصحية تخسر الملايين من خلال تأخير الجودة فشل إعادة صياغة ، والتوقف.
حتى مع الخبرة الكبيرة أعلى البائعين المبادرات تفشل عند التنفيذ لا يتحكم بها.
قمنا ببناء نموذج عملي يجمع بين السريرية مصداقية التنفيذية الانضباط—حتى قادة الحد من المخاطر في وقت مبكر ، انتقل للعيش مع الثقة والحفاظ على الأداء بعد فترة طويلة من إطلاق.
تسليم نموذج
نأتي هيكل إلى التعقيد من خلال تسليم الضوابط أن النظم الصحية والمختبرات يمكن أن تثق
فريق التسليم
DealBridge العالمية بقيادة أحد كبار, مشغل بقيادة الفريق الأساسية ، مدعومة برعاية شبكة مختبر الطب و الأمراض الخبراء حسب الحاجة.
نحن تغطي عمليات سير العمل ، جودة/الاعتماد التحقق من صحة/التحقق من البيانات + AI دعم القرار.
الخبرة يمتد الرئيسية مختبر التخصصات—حفظ تسليم عملية للمساءلة ، وقابلة للتطوير.
المبادئ
القيم التي تترجم إلى التنفيذ. قرارات واضحة ومساءلة أصحاب لمراجعة النتائج.
القرارات ومدى التوقعات صريحة
أصحاب, مواعيد, دليل, والنتائج تتبع
الموثوقية وإمكانية التتبع و المريض تأثير الأولى
الانحياز أصحاب المصلحة في عملية التسليم ، لا ألوم الثقافة
بائع محايدة المخاطر علم الأدلة مدفوعة
مؤسس العمليات التي يقودها الحكم.
تسليم الدعم والشراكات عبر تحديد التعاقدات.
النمو الأساسية في السوق—الرياض ودبي الأولوية (الحضور الإقليمي المخطط).
الشرق الأوسط وأفريقيا وآسيا معتمدة على أساس المشروع تناسب التوافق الاستراتيجي.
أين
نساعد المستشفيات والمختبرات وشركاء الرعاية الصحية على تنفيذ مبادرات التشخيص والتكنولوجيا المعقدة، وذلك من خلال رؤى سريرية، وحوكمة منظمة، وتنفيذ دقيق.
يقابلنا
مؤسس تقودها القيادة المعززة من قبل كبار المستشارين في مختبر الطب, علم الأمراض, الجودة, مختبر البيانات & AI. نأتي الحكم و تسليم الانضباط الذي يحمي المرضى ، والميزانيات ، والنتائج.
Founder & Managing Director | DealBridge Global
Dr. Ghulam Dhabaan, PhD, FCCM, D(ABMM), is a board-certified Clinical Microbiologist and Founder of DealBridge Global, a diagnostics advisory, innovation, and execution firm. Trained across University of Toronto–affiliated hospitals, he specializes in transforming complex laboratory systems into high-performance, outcome-driven operations. His work integrates AI-enabled diagnostics, automation, and antimicrobial stewardship to bridge the gap between data, decisions, and clinical impact. Published in Nature Microbiology and The Lancet Microbe, he advises on large-scale diagnostic transformation initiatives across North America and the GCC.
Professor & Head, Clinical Biochemistry | SickKids & University of Toronto | Past President, IFCC
Dr. Khosrow Adeli is Professor and Head of Clinical Biochemistry at the Hospital for Sick Children and the University of Toronto. He served as President of the IFCC (2020–2023) and is Editor-in-Chief of Critical Reviews in Clinical Laboratory Sciences. A fellow of the Canadian Academy of Clinical Biochemistry and diplomate of the American Board of Clinical Biochemistry, he has received numerous distinctions including the University of Toronto Hegele Award and the ADLM Outstanding Research Award. Principal Investigator of the globally adopted CALIPER pediatric reference interval database. Author of 500+ publications.
Founder & MD, Q3CG | Executive Director, QRI | Ann Arbor, Michigan
Dr. Walid Qoronfleh is Executive Director of Q3 Research Institute (QRI) and co-Founder of Q3CG, a boutique healthcare consultancy in Michigan. With 20+ years in precision medicine, AI, and laboratory medicine, he has held senior executive roles at GSK, Sanofi, Thermo Fisher, and the NIH-NCI. He has secured nearly US$20M in funded research and published 145+ peer-reviewed papers and four books, including a best-book award winner. Founder of six biotech companies with three successful exits. Holds graduate degrees from the University of Louisville, Penn State, and University of Wisconsin–Madison.
Group Laboratory Director, Operations & Innovation | American Hospital Dubai
Dr. Hady Elkhodary is a healthcare executive and clinical laboratory leader with 20+ years optimizing diagnostics across Canada and the Middle East. As Group Laboratory Director at American Hospital Dubai, he steers multi-site total laboratory automation, genomics expansion, and data-driven quality programs that have reduced turnaround times and delivered millions in operational savings. A recognized expert in ISO 15189 and CAP accreditation, LIS integration (Oracle Health, TrakCare), and value-based care strategy, he consults with GCC health systems on operational excellence and advances predictive analytics to close diagnostic gaps.
نحن جاهزون
مكالمة قصيرة لفهم القيود والمخاطر والنتائج المرجوة—ثم تحديد أسرع التحكم في المسار إلى نتائج قابلة للقياس.
مكالمة قصيرة لفهم القيود والمخاطر والنتائج المرجوة—ثم تحديد أسرع التحكم في المسار إلى نتائج قابلة للقياس.
نحن نربط بين الخبرة السريرية وفرق التنفيذ لتقديم مشاريع تشخيصية مع التحكم والاستقرار والنتائج القابلة للقياس.
تورنتو ، أونتاريو ، كندا
